Warning! GuruFocus detected
3 Severe warning signs
with WSG.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
China Traditional Chinese Medicine Holdings Co Ltd
ISIN : HK0000056256
Share Class Description:
STU:WSG: Ordinary SharesCompare
Compare
Traded in other countries / regions
00570.Hong KongWSG.GermanyCHIZF.USA IPO Date
2015-10-16Description
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.33 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | 9.98 | |||||
| Interest Coverage | 3.92 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.69 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | -9.3 | |||||
| 3-Year EPS without NRI Growth Rate | -11.4 | |||||
| 3-Year Book Growth Rate | 2.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 18.79 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.4 | |||||
| 9-Day RSI | 42.98 | |||||
| 14-Day RSI | 44.6 | |||||
| 3-1 Month Momentum % | -11.94 | |||||
| 6-1 Month Momentum % | -52.61 | |||||
| 12-1 Month Momentum % | -52.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | |||||
| Quick Ratio | 1.8 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 231.31 | |||||
| Days Sales Outstanding | 204.07 | |||||
| Days Payable | 110.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -0.6 | |||||
| Forward Dividend Yield % | 0.19 | |||||
| Shareholder Yield % | 9.98 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.59 | |||||
| Operating Margin % | 5.61 | |||||
| Net Margin % | 0.34 | |||||
| FCF Margin % | 11.44 | |||||
| ROE % | 0.26 | |||||
| ROA % | 0.15 | |||||
| ROIC % | 0.46 | |||||
| 3-Year ROIIC % | -36.45 | |||||
| ROC (Joel Greenblatt) % | 2.4 | |||||
| ROCE % | 1.45 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 165 | |||||
| Forward PE Ratio | 10.36 | |||||
| PE Ratio without NRI | 198 | |||||
| Shiller PE Ratio | 6.18 | |||||
| Price-to-Owner-Earnings | 17.07 | |||||
| PS Ratio | 0.56 | |||||
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| Price-to-Free-Cash-Flow | 4.79 | |||||
| Price-to-Operating-Cash-Flow | 3.88 | |||||
| EV-to-EBIT | 26.89 | |||||
| EV-to-Forward-EBIT | 10.06 | |||||
| EV-to-EBITDA | 26.89 | |||||
| EV-to-Forward-EBITDA | 6.79 | |||||
| EV-to-Revenue | 0.65 | |||||
| EV-to-Forward-Revenue | 0.87 | |||||
| EV-to-FCF | 5.44 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-Median-PS-Value | 0.26 | |||||
| Price-to-Graham-Number | 2.49 | |||||
| Price-to-Net-Current-Asset-Value | 1.87 | |||||
| Earnings Yield (Greenblatt) % | 3.72 | |||||
| FCF Yield % | 20.4 | |||||
| Forward Rate of Return (Yacktman) % | -3.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Traditional Chinese Medicine Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,139.446 | ||
| EPS (TTM) (€) | 0.001 | ||
| Beta | 0.11 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 59.15 | ||
| 14-Day RSI | 44.6 | ||
| 14-Day ATR (€) | 0.005496 | ||
| 20-Day SMA (€) | 0.2303 | ||
| 12-1 Month Momentum % | -52.8 | ||
| 52-Week Range (€) | 0.22 - 0.515 | ||
| Shares Outstanding (Mil) | 5,035.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Traditional Chinese Medicine Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Traditional Chinese Medicine Holdings Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
China Traditional Chinese Medicine Holdings Co Ltd Frequently Asked Questions
What is China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG)'s stock price today?
The current price of STU:WSG is €0.22. The 52 week high of STU:WSG is €0.52 and 52 week low is €0.22.
When is next earnings date of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG)?
The next earnings date of China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) is .
Does China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) pay dividends? If so, how much?
China Traditional Chinese Medicine Holdings Co Ltd(STU:WSG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers